{
    "clinical_study": {
        "@rank": "24891", 
        "arm_group": [
            {
                "arm_group_label": "Animal Compound Free Medium", 
                "arm_group_type": "Experimental", 
                "description": "Patients in this arm receive a corneal graft stored in organ culture in a animal compound free medium"
            }, 
            {
                "arm_group_label": "organ culture medium containing 2% of f\u0153tal calf serum", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients in this arm receive a corneal graft stored in organ culture in a commercial organ culture medium containing 2% of f\u0153tal calf serum"
            }
        ], 
        "brief_summary": {
            "textblock": "At present, all commercially available corneal organ culture media contain foetal calf serum\n      (FCS) and sometimes other compounds extracted from animals. These compounds are necessary\n      for corneal cell survival but are problematic because they theoretically have risk of\n      anthropozoonosis transmission, especially for new variant of CJD and the variability between\n      FCS batches influence graft quality. Our laboratory research allowed in vitro and ex vivo\n      validation of a new medium free compound animal. We proved its superiority over conventional\n      medium containing 2% FCS for endothelial cell survival during the storage time. The goal of\n      this clinical trial is now to assess its superiority in patients."
        }, 
        "brief_title": "Comparative Study of Two Corneal Graft Storage Media: New Animal Compound Free Medium Versus Reference Medium", 
        "completion_date": {
            "#text": "February 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Corneal Transplantation", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male and female patients\n\n          -  over 18 years of age\n\n          -  Clinically proven corneal disease\n\n          -  Registered on the French National waiting list (GLAC)\n\n          -  Patient informed consent\n\n          -  Patient who needs a 8.25mm of diameter perforating keratoplasty, either isolated or\n             combined with lens surgery\n\n          -  Low immune rejection risk (< 2 quadrants of neovascularization, no previous history\n             of herpetic keratitis nor graft rejection)\n\n          -  No previous history of glaucoma or elevated intra ocular pressure (>22 mm\n\n        Exclusion Criteria:\n\n          -  Patient is unlikely to comply with the requirements of the protocol"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "122", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 25, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01694914", 
            "org_study_id": "0908018", 
            "secondary_id": "2010-A00234-35"
        }, 
        "intervention": {
            "arm_group_label": [
                "Animal Compound Free Medium", 
                "organ culture medium containing 2% of f\u0153tal calf serum"
            ], 
            "intervention_name": "corneal graft", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Corneal Transplantation", 
            "corneal organ culture medium", 
            "free animal compound medium"
        ], 
        "lastchanged_date": "November 6, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Besancon", 
                        "country": "France", 
                        "zip": "25000"
                    }, 
                    "name": "CHU Besan\u00e7on"
                }, 
                "investigator": {
                    "last_name": "Bernard Delbosc, MD-PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Clermont-Ferrand", 
                        "country": "France", 
                        "zip": "63003"
                    }, 
                    "name": "CHU Clermont-Ferrand"
                }, 
                "investigator": {
                    "last_name": "Fr\u00e9d\u00e9ric Chiambaretta, MD-PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Grenoble", 
                        "country": "France", 
                        "zip": "38043"
                    }, 
                    "name": "CHU Grenoble"
                }, 
                "investigator": {
                    "last_name": "Jean-Paul Romanet, MD-PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Saint-Etienne", 
                        "country": "France", 
                        "zip": "42055"
                    }, 
                    "name": "CHU Saint-Etienne"
                }, 
                "investigator": {
                    "last_name": "Gilles Thuret, MD-PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Comparative Study of Two Corneal Graft Storage Media: New Animal Compound Free Medium Versus Reference Medium", 
        "overall_contact": {
            "email": "gilles.thuret@univ-st-etienne.fr", 
            "last_name": "Gilles Thuret, MD-PhD", 
            "phone": "(0)477120570", 
            "phone_ext": "+33"
        }, 
        "overall_contact_backup": {
            "email": "carine.labruyere@chu-st-etienne.fr", 
            "last_name": "Carine Labruyere, CRA", 
            "phone": "(0)477120469", 
            "phone_ext": "+33"
        }, 
        "overall_official": {
            "affiliation": "CHU Saint-Etienne", 
            "last_name": "Gilles Thuret, MD-PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "February 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "the primary outcome is the endothelial cell density (ECD) of the corneal grafts.", 
            "safety_issue": "No", 
            "time_frame": "one year after graft"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01694914"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Centre Hospitalier Universitaire de Saint Etienne", 
        "sponsors": {
            "collaborator": {
                "agency": "Ministry of Health, France", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Centre Hospitalier Universitaire de Saint Etienne", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}